BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 15052326)

  • 1. Acid and neutral sphingomyelinases: roles and mechanisms of regulation.
    Marchesini N; Hannun YA
    Biochem Cell Biol; 2004 Feb; 82(1):27-44. PubMed ID: 15052326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo C16- and C24-ceramide generation contributes to spontaneous neutrophil apoptosis.
    Seumois G; Fillet M; Gillet L; Faccinetto C; Desmet C; François C; Dewals B; Oury C; Vanderplasschen A; Lekeux P; Bureau F
    J Leukoc Biol; 2007 Jun; 81(6):1477-86. PubMed ID: 17329567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of sphingomyelinases in TNF signaling pathways.
    Krönke M
    Chem Phys Lipids; 1999 Nov; 102(1-2):157-66. PubMed ID: 11001570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological roles of Acid and neutral sphingomyelinases and their regulation by nitric oxide.
    Perrotta C; Clementi E
    Physiology (Bethesda); 2010 Apr; 25(2):64-71. PubMed ID: 20430951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate.
    Claus RA; Dorer MJ; Bunck AC; Deigner HP
    Curr Med Chem; 2009; 16(16):1978-2000. PubMed ID: 19519377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide: a stress signal and mediator of growth suppression and apoptosis.
    Obeid LM; Hannun YA
    J Cell Biochem; 1995 Jun; 58(2):191-8. PubMed ID: 7673327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARalpha agonist induces the accumulation of ceramide in the heart of rats fed high-fat diet.
    Baranowski M; Błachnio A; Zabielski P; Górski J
    J Physiol Pharmacol; 2007 Mar; 58(1):57-72. PubMed ID: 17440226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic GMP-dependent inhibition of acid sphingomyelinase by nitric oxide: an early step in protection against apoptosis.
    Barsacchi R; Perrotta C; Sestili P; Cantoni O; Moncada S; Clementi E
    Cell Death Differ; 2002 Nov; 9(11):1248-55. PubMed ID: 12404124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a sphingomyelinase activity in Saccharomyces cerevisiae.
    Ella KM; Qi C; Dolan JW; Thompson RP; Meier KE
    Arch Biochem Biophys; 1997 Apr; 340(1):101-10. PubMed ID: 9126282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingomyelin-degrading pathways in human cells role in cell signalling.
    Levade T; Andrieu-Abadie N; Ségui B; Augé N; Chatelut M; Jaffrézou JP; Salvayre R
    Chem Phys Lipids; 1999 Nov; 102(1-2):167-78. PubMed ID: 11001571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
    Adada M; Luberto C; Canals D
    Chem Phys Lipids; 2016 May; 197():45-59. PubMed ID: 26200918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
    Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
    Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signalling sphingomyelinases: which, where, how and why?
    Levade T; Jaffrézou JP
    Biochim Biophys Acta; 1999 Apr; 1438(1):1-17. PubMed ID: 10216276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus.
    Mikati MA; Zeinieh M; Habib RA; El Hokayem J; Rahmeh A; El Sabban M; Usta J; Dbaibo G
    Epilepsy Res; 2008 Oct; 81(2-3):161-6. PubMed ID: 18603412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceramide-induced cell death in malignant cells.
    Carpinteiro A; Dumitru C; Schenck M; Gulbins E
    Cancer Lett; 2008 Jun; 264(1):1-10. PubMed ID: 18353542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingomyelin hydrolysis during apoptosis.
    Andrieu-Abadie N; Levade T
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):126-34. PubMed ID: 12531545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.
    Levade T; Vidal F; Vermeersch S; Andrieu N; Gatt S; Salvayre R
    Biochim Biophys Acta; 1995 Oct; 1258(3):277-87. PubMed ID: 7548198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extended family of neutral sphingomyelinases.
    Clarke CJ; Snook CF; Tani M; Matmati N; Marchesini N; Hannun YA
    Biochemistry; 2006 Sep; 45(38):11247-56. PubMed ID: 16981685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of sphingomyelin and ceramide cellular levels after sphingomyelinase-mediated sphingomyelin hydrolysis.
    Santana P; Fanjul LF; Ruiz de Galarreta CM
    Methods Mol Biol; 1998; 105():217-21. PubMed ID: 10427565
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine release in PC12 cells is mediated by Ca(2+)-dependent production of ceramide via sphingomyelin pathway.
    Jeon HJ; Lee DH; Kang MS; Lee MO; Jung KM; Jung SY; Kim DK
    J Neurochem; 2005 Nov; 95(3):811-20. PubMed ID: 16135082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.